UK Markets closed
  • FTSE 100

    +81.64 (+1.04%)
  • FTSE 250

    -21.23 (-0.10%)
  • AIM

    +1.03 (+0.12%)

    -0.0048 (-0.43%)

    -0.0159 (-1.3035%)

    -394.36 (-1.98%)
  • CMC Crypto 200

    +1.80 (+0.34%)
  • S&P 500

    -27.60 (-0.66%)
  • DOW

    -75.10 (-0.22%)

    -2.01 (-2.65%)

    -54.10 (-2.80%)
  • NIKKEI 225

    +107.41 (+0.39%)

    -297.89 (-1.36%)
  • DAX

    -32.76 (-0.21%)
  • CAC 40

    +67.67 (+0.94%)

Lipid Based Formulations Global Market Report 2023: Rapidly Expanding Pharmaceutical Industry and Rising Demand for Advanced Medicines Boosts Growth

Company Logo
Company Logo

Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The "Lipid Based Formulations Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Source of Lipids (Natural v/s Chemically Synthesized), By Application, By Distribution Channel, By Region" report has been added to's offering.

Global lipid based formulations market is anticipated to grow with an impressive CAGR in the forecast period, 2023-2027, on account of growing pharmaceutical industry. Rapidly surging demands for the advanced medicine and growing demand for oral administrated medicine is driving the growth of the global lipid formulations market in the upcoming five years.

Lipid based formulations are bio-chemical compounds that are artificially synthesized to facilitate the drug administration, while ensuring safety of the drug along with bio-solubility of it for the digestion and faster action of the main drug component inside the formulation. Lipid based formulations aid the primary mechanism of action for the drug that leads to bioavailability.

In simpler terms, highly water soluble drugs if gets dissolved in the starting of gut, may not reach the target site, or target organ and thus its efficiency decreases. To alter this effect, a lipid based formulation is utilized. Lipids form a hydrophobic bonds around the drug and avoid dissolution partially or completely until it reaches the target site. With digestion of the lipid bonds by the process of triglyceride digestion, the drug gets delivered in the later parts of gastrointestinal tract.

Pharmaceutical Advancements Drive Market Growth

Consistent research and development of the drugs such that they have higher bio-availability, higher effect on the target site, to improve facilitation of the drug to create its effect at the target site, is driving the growth of the global lipid based formulations market in the upcoming five years. A major concern among the drug delivery system is that, for the oral administration of the drug, it has tendency to get dissolved or digested before reaching the target site.

In such cases, the drug if get dissolved would leave the gastrointestinal tract without being absorbed in the blood. To avoid this untimely dissolution, lipid based formulations are utilized to enhance the drug durability and absorption thus substantially increasing its affinity as a treatment for a particular diseases.

Growing Investments In Healthcare Industry Supports Market

Governments from major economies are actively investing in their respective healthcare sectors to enhance the services and products such that best possible patient care can be provided. Increasing instances of chronic, infectious, and communicable diseases, is further anticipated to drive the growth of the global lipid based formulations market in the upcoming five years. Consistent research and technological advancement for the pharmaceutical product development and advancement of the drug delivery systems, is also anticipated to substantiate the growth of the global lipid based formulations market in the future five years.

Company Profile

Novartis AG, AbbVie, Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Alnylam Pharmaceuticals Inc., are enlisted in a partial list of major market players of the global lipid based formulations market.

Report Scope:

In this report, global lipid based formulations market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Lipid Based Formulations Market, By Source of Lipids:

  • Natural

  • Chemically Synthesized

Lipid Based Formulations Market, By Application:

  • Fungal Diseases

  • Oncology

  • Gene Therapy

  • Antiviral Vaccines

  • Others

Lipid Based Formulations Market, By Distribution Channel:

  • Retail Pharmacies

  • Hospital Pharmacies

  • Online Pharmacies

Lipid Based Formulations Market, By Region:

  • North America

  • United States

  • Mexico

  • Canada

  • Europe

  • France

  • Germany

  • United Kingdom

  • Italy

  • Spain

  • Asia-Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • South America

  • Brazil

  • Argentina

  • Colombia

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Lipid Based Formulations Market

4. Executive Summary

5. Voice of Customer

6. Clinical Trials

7. Patent Analysis

8. List of Commercially Available Lipid Based Formulations

9. Global Lipid Based Formulations Market Outlook

10. North America Lipid Based Formulations Market Outlook

11. Europe Lipid Based Formulations Market Outlook

12. Asia-Pacific Lipid Based Formulations Market Outlook

13. South America Lipid Based Formulations Market Outlook

14. Middle East and Africa Lipid Based Formulations Market Outlook

15. Market Dynamics

16. Market Trends & Developments

17. Competitive Landscape

18. Strategic Recommendations

A selection of companies mentioned in this report includes

  • Novartis AG

  • AbbVie, Inc.

  • F. Hoffmann-La Roche AG

  • Johnson & Johnson

  • Alnylam Pharmaceuticals Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900